{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:57:31Z","timestamp":1780696651959,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.jsbmb.2004.02.010","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T02:42:27Z","timestamp":1089254547000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague\u2013Dawley rats by ormeloxifene, a selective estrogen receptor modulator"],"prefix":"10.1016","volume":"91","author":[{"given":"M.","family":"Arshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sawlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2004.02.010_BIB1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm1096-1077","article-title":"Estrogen and bone: new pieces to the puzzle","volume":"2","author":"Raisz","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone disease","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(96)07365-5","article-title":"Risk of endometrial cancer in relation use of oestrogen combined with cyclic progestagen therapy in postmenopausal women","volume":"349","author":"Beresford","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of post-menopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.1011","article-title":"Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone related clinical disorder","volume":"21","author":"Singh","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","author":"Black","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB9","unstructured":"H.U. Bryant, J.A. Dodge, Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease, US Patent 5407955, Eli Lilly and Company, Indianapolis, IN (1995)."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB10","first-page":"380","article-title":"Raloxifene and post-menopausal osteoporosis","volume":"60","author":"Clemett","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/rtph.1997.1108","article-title":"Activity of raloxifene in immature and ovariectomized rat uterotrophic assays","volume":"25","author":"Ashby","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1530\/rep.0.1210915","article-title":"Oestrogenic effect of neonatal administration of raloxifene on hypothalamic\u2013pituitary\u2013gonadal axis in male and female rats","volume":"121","author":"Pinilla","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB13","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/jm00174a018","article-title":"Structure\u2013activity relationship of antiestrogens: studies on 2,3-diaryl-1-benzopyrans","volume":"33","author":"Saeed","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1248\/bpb1978.10.487","article-title":"The establishment of a new biological assay system for simultaneous measurement of bone resorption and bone mineralization in organ cultures of chick embryonic femur","volume":"10","author":"Saito","year":"1987","journal-title":"J. Pharmacobio-Dyn."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1254\/jjp.65.343","article-title":"Effect of KCA-098 on bone metabolism: comparison with those of ipriflavone","volume":"65","author":"Tsutsumi","year":"1994","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB16","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB17","first-page":"69","article-title":"The ovariectomized rat as an animal model for postmenopausal bone loss","volume":"1","author":"Wronski","year":"1991","journal-title":"Cell. Mater. Suppl."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1210\/endo.138.5.5109","article-title":"Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats","volume":"138","author":"Jimnez","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB19","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1016\/0002-9343(91)90251-R","article-title":"Biochemical marker of bone turnover in diagnosis and assessment of therapy","volume":"91","author":"Riis","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB20","unstructured":"J.H. Zar, Biostatistical Analysis, Prentice Hall, New Jersey, 1974, pp. 151\u2013155."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB21","first-page":"13","article-title":"Calcitonin: osteoporosis treatment and prevention","volume":"36","author":"Munoz","year":"2000","journal-title":"Drugs Today"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB22","unstructured":"M. Arshad, S. Sengupta, S. Sharma, R. Ghosh, B.R. Verma, V. Sawlani, M.M. Singh, Bone turnover rate in female Sprague\u2013Dawley rats: an age related study, in: Proceedings of II Symp. Curr. Adv. Mol. Biochem.: Application in Health, Environment and Agriculture, 2000, P-3\/10 (abstract)."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem-72-2-382","article-title":"The course of biochemical parameters of bone turnover during treatment with corticosteroids","volume":"72","author":"Prummel","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB24","first-page":"755","article-title":"Efficacy of levormeloxifene in the prevention of post-menopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy","volume":"86","author":"Alexandersen","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/jm00031a020","article-title":"An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman","volume":"33","author":"Ray","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB26","first-page":"S347","article-title":"Levormeloxifene, a non-steroidal, partial estrogen agonist, prevents bone loss, reduces serum cholesterol and exerts a non-proliferative action on uterine tissue in the ovariectomized rats","volume":"12","author":"Bain","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB27","unstructured":"J.R. Piggott, Bothell, 3,4-Diarylchromans for treatment of dermatitis, US Patent no. 5451603, ZymoGenetics Inc., Seattle, WA (1995)."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB28","unstructured":"J.R. Piggott, Bothell, 3,4-Diarylchromans for treatment of calmodulin activity, US Patent no. 5480903, ZymoGenetics Inc., Seattle, WA (1996)."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01806132","article-title":"Effect of antiestrogens on bone in castrated and intact female rats","volume":"10","author":"Jordan","year":"1987","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB30","first-page":"1144","article-title":"Biological profile of centchroman\u2014a new postcoital contraceptive","volume":"15","author":"Kamboj","year":"1977","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0010-7824(92)90144-I","article-title":"CDRI-85\/287, a novel antiestrogen and anti-implantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus","volume":"45","author":"Sreenivasulu","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/endo-118-1-125","article-title":"Effects of antiestrogens tamoxifen and clomiphene on bone resorption in vitro","volume":"118","author":"Stewart","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1006\/bbrc.1995.2673","article-title":"The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro","volume":"216","author":"Hall","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB34","first-page":"242","article-title":"Results on international clinical trials with raloxifene","volume":"60","author":"Agniusdei","year":"1999","journal-title":"Annals Endocrinol. (Paris)"},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0960-0760(00)00087-X","article-title":"Prevention of bone loss by EM-800 raloxifene in the ovariectomized rat","volume":"74","author":"Martel","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.02.010_BIB36","first-page":"1145","article-title":"Effect of prolonged centchroman treatment on pituitary gonadotrophic activity in rhesus monkey","volume":"29","author":"Singh","year":"1991","journal-title":"Indian J. Exp. Biol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:48:05Z","timestamp":1760734085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076004002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0960076004002262"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.02.010","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague\u2013Dawley rats by ormeloxifene, a selective estrogen receptor modulator","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}